Levodopa/Carbidopa Teva

Levodopa, Carbidopa, the active ingredients in Levodopa/Carbidopa Teva, are a dopamine precursor and a dopa decarboxylase inhibitor presented as an oral dosage form for oral use. They are employed to treat Parkinson's disease by restoring dopaminergic activity in patients. GNH USA supplies Levodopa/Carbidopa Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Carbidopa acts on the dopaminergic pathway to manage Parkinsonian disorders. - Parkinson's disease (early stage): improves motor function and reduces tremor. - Parkinson's disease (advanced stage): lessens off‑periods and enhances daily activity. - Parkinsonian syndrome secondary to medication: alleviates rigidity and bradykinesia.

Levodopa/Carbidopa may cause a range of adverse reactions.

Common Side Effects: - Nausea or vomiting - Orthostatic hypotension - Dizziness or light‑headedness - Dyskinesia (involuntary movements) - Dry mouth - Insomnia

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Severe depression or suicidal thoughts - Cardiac arrhythmias - Hallucinations or psychosis - Severe orthostatic hypotension leading to falls

Before initiating therapy, consider the following precautions. - Renal impairment: adjust dose and monitor renal function. - Hepatic disease: use with caution, assess liver enzymes. - Cardiovascular disorders: monitor blood pressure and heart rate. - Psychiatric history: watch for mood changes or hallucinations. - Concomitant MAO‑B inhibitors: avoid due to risk of hypertensive crisis. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Levodopa/Carbidopa can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (e.g., haloperidol): may diminish therapeutic effect. - High‑dose pyridoxine (vitamin B6): increases peripheral levodopa metabolism.

Moderate Interactions (Monitor Closely): - Iron or calcium supplements: reduce levodopa absorption; separate dosing by at least 2 hours. - Antihypertensives: may exacerbate orthostatic hypotension. - SSRIs or SNRIs: monitor for serotonin syndrome when combined with MAO‑B inhibitors.